05.05.2019, 3694 Zeichen

Palfinger: The Palfinger Group, world’s leading manufacturers of innovative lifting solutions, continued to record satisfactory growth in the first quarter of 2019. Revenue rose from Euro 394.2 mn by 11.8 per cent to Euro 440.9 mn, EBIT showed a significant year-on-year increase of 27.3 per cent. In terms of both revenue and earnings, Palfinger achieved record levels for quarterly figures. The main contributors to the satisfactory rise in revenue in the first quarter of 2019 were the regions NAM (North America) and EMEA. EBIT reached Euro 42.7 mn, as compared to Euro 33.6 mn in the first quarter of 2018. The consolidated net result increased as well, from Euro 17.9 mn to Euro 21.1 mn.
Palfinger: weekly performance: 2.68%

Amag: The Amag Group, Austrian premium supplier of high-quality aluminium cast and flat rolled products, reported an increase in revenue by 4 % year-on-year to Euro 274.4 mn, which is attributable, in particular, to the higher volume in the Rolling Division. Earnings before interest and taxes (EBIT) for the Amag Group amounted to Euro 12.8 mn, after Euro 18.6 mn in the first quarter of 2018. Net income after taxes amounted to Euro 7.6 mn in the first quarter of 2019 (Q1 2018: Euro 12.9 mn).
Amag: weekly performance: 0.32%

Marinomed: In 2018, the biopharmaceutical company Marinomed Biotech AG posted revenues of around Euro 4.7 mn (2017: Euro 4.8 mn). Results were negative, in line with planning, and reflected Marinomed’s high investments in its future growth path. The operating result (EBIT) came in at Euro -5.1 mn (2017: Euro -1.6 mn), notably due to higher R&D expenses and one-off costs in connection with the IPO. In addition, the financial result was burdened by a one-off, non-cash valuation result of EUR -5.7 million in connection with the convertible bond issued in 2017. The loss for the year therefore came in at Euro -12.1 mn (2017: Euro -2.4 mn). Adjusted for the one-off special effects (valuation of the convertible bond and IPO costs), the loss for the year in 2018 was Euro -4.6 mn. Due to the high research and development expenses, the company anticipates continuing operating losses for the coming years.
Marinomed Biotech: weekly performance: -1.26%

ams: ams, the Swiss-listed Austrian based supplier of high performance sensor solutions, reports first quarter results. Revenue in the three months through March fell 20 percent from the fourth quarter of 2018 to USD 390.2 mn, at the upper end of its guidance. The operating margin came in at 6 percent, with adjusted earnings before interest and tax (EBIT) at USD 23.5 mn. ams expects second-quarter revenue of USD 390-430 mn and an operating margin of around 10 percent.
AMS: weekly performance: 34.39%

KapschTrafficCom:  Kapsch TrafficCom, provider of intelligent transportation systems in the fields of tolling, traffic management, smart urban mobility, traffic safety and security, and connected vehicles, announced an important court decision in the United States regarding the legal dispute with Neology, Inc. The latter claimed a violation of its patents by Kapsch importing electronic tolling products which use the ISO/IEC 18000-6Ccommunications protocol (6C Standard). On April 19, the U.S. Court of Appeals for the Federal Circuit confirmed that the subject patent claims are invalid and, hence, affirmed the International Trade Commission (ITC) decision. Several of Neology’s 6C Standard patent claims were already invalidated by the United States Patent and Trademark Office (USPTO) in 2015, and the ITC had rejected as invalid several more claims in 2017.
Kapsch TrafficCom: weekly performance: -1.20%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (30/04/2019)

Christian Drastil: Wiener Börse Plausch

Private Investor Relations Podcast #34: Christoph Rainer, gestern noch UBM-IR, heute schon Asta Energy Solutions-IR und gleich im Podcast

Bildnachweis

Aktien auf dem Radar:Austriacard Holdings AG, Mayr-Melnhof, Bajaj Mobility AG, Zumtobel, Amag, Agrana, Porr, Semperit, Polytec Group, Kapsch TrafficCom, Verbund, DO&CO, FACC, Frauenthal, Frequentis, Reploid Group AG, CPI Europe AG, Linz Textil Holding, RBI, Uniqa, VIG, EuroTeleSites AG, Österreichische Post, Telekom Austria, Zalando, Microsoft, IBM, salesforce.com, Fresenius Medical Care, Merck KGaA, Airbus Group.

---